SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

DermTech, Inc. 
 CA
  SEC # 1651944


        
Related Registrant:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

172  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
5/4/2310-Q1And December 31, 202
8/3/2310-Q1And S
2/29/2410-K1Business
4/26/24New Filing!  10-K/A1Certain Relationships and Related Transactions, and Director Independence
2/29/2410-K1Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
8/3/2310-Q1Condensed Consolidated Balance Sheets as of
11/2/2310-Q1Condensed Consolidated Balance Sheets as of September 30, 2023 and December 31, 2022
8/3/2310-Q1Condensed Consolidated Statements of Cash Flows for
11/2/2310-Q1Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2023 and 2022
5/4/2310-Q1Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2023 and 2022
8/3/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the Three
11/2/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the Three and Nine Months Ended September 30, 2023 and 2022
5/4/2310-Q1Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2023 and 2022
8/3/2310-Q1Condensed Consolidated Statements of Operations for the Three
11/2/2310-Q1Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2023 and 2022
5/4/2310-Q1Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2023 and 2022
8/3/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the Three
11/2/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended September 30, 2022
1Condensed Consolidated Statements of Stockholders' Equity for the Three and Nine Months Ended September 30, 2023
8/3/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the Three and Six Months Ended June 30, 2022
5/4/2310-Q1Condensed Consolidated Statements of Stockholders' Equity for the Three Months Ended March 31, 2023 and 2022
2/29/2410-K1Consolidated Balance Sheets as of December 31, 2023 and 2022
1Consolidated Financial Statements and Supplementary Data
1Consolidated Statements of Cash Flows for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Operations and Comprehensive Loss for the Years Ended December 31, 2023 and 2022
1Consolidated Statements of Stockholders' Equity for the Years Ended December 31, 2023 and 2022
1Controls and Procedures
1Cybersecurity
4/26/24New Filing!  10-K/A1Directors, Executive Officers and Corporate Governance
2/29/2410-K1Disclosure Regarding Foreign Jurisdictions that Prevent Inspection
5/9/23DEFA14A1Employment Agreement, dated May 6, 2023 by and between the Company and Bret Christensen
4/26/24New Filing!  10-K/A1Executive Compensation
11/2/2310-Q1Exhibits
4/26/24New Filing!  10-K/A1Exhibits and Financial Statement Schedules
11/2/2310-Q1Financial Information
1Financial Statements (Unaudited)
2/29/2410-K1Form 10-K Summary
11/2/2310-Q1Item
2/29/2410-K1Item 1
4/26/24New Filing!  10-K/A1Item 10
1Item 11
1Item 12
1Item 13
1Item 14
1Item 15
2/29/2410-K1Item 16
1Item 1A
1Item 1B
1Item 1C
1Item 2
1Item 3
1Item 4
1Item 5
1Item 6
1Item 7
1Item 7A
1Item 8
1Item 9
1Item 9A
1Item 9B
1Item 9C
8/3/2310-Q1June 30
2/29/2410-K1Legal Proceedings
1Management's Discussion and Analysis of Financial Condition and Results of Operations
5/4/2310-Q1March 31
2/29/2410-K1Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
1Mine Safety Disclosures
8/3/2310-Q1Months Ended
1Ne 30
2/29/2410-K1Notes to Consolidated Financial Statements
11/2/2310-Q1Notes to Unaudited Condensed Consolidated Financial Statements
2/29/2410-K1Other Information
1Part I
1Part II
4/26/24New Filing!  10-K/A1Part III
1Part IV
3/7/24S-81Powers of Attorney (included on signature page to this Registration Statement)
2/29/2410-K1Powers of Attorney (included on signature page)
5/9/23DEFA14A1Press Release, dated May 9, 2023
4/26/24New Filing!  10-K/A1Principal Accountant Fees and Services
2/29/2410-K1Properties
1Quantitative and Qualitative Disclosures About Market Risk
1Report of Independent Registered Public Accounting Firm
1Reserved
1Risk Factors
5/9/23DEFA14A1Second Amended and Restated 2022 Inducement Equity Incentive Plan
4/26/24New Filing!  10-K/A1Security and Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
1Signatures
11/2/2310-Q1Table of Contents
8/3/2310-Q1The
2/29/2410-K1Unresolved Staff Comments
1110
1111
1112
1116
1117
5/4/2310-Q1202
8/3/2310-Q12023
12023 and 2022
12023 and December 31, 2022

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 15, 4:47:32.2am ET